Research Article
Uncaria tomentosa—Adjuvant Treatment for Breast Cancer: Clinical Trial
Table 2
Leukocytes, neutrophils, lymphocytes, and monocytes levels in breast cancer patients before treatment and after 6 cycles of chemotherapy without Uncaria tomentosa supply (Ca group) or receiving 300 mg/day of Uncaria tomentosa (UtCa group).
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data expressed asmean ± standard deviation. *Represent difference significant between the Ca and UtCa groups, P < 0.05. #Represent difference significant of the control group, P < 0.05 (Student’s t-test). |